NDC 36987-1466
Black Olive
Black Olive
Black Olive is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Black Olive.
| Product ID | 36987-1466_dec580ea-73db-4658-9de1-440c19bb42b7 |
| NDC | 36987-1466 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Black Olive |
| Generic Name | Black Olive |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Nelco Laboratories, Inc. |
| Substance Name | BLACK OLIVE |
| Active Ingredient Strength | 0 g/mL |
| Pharm Classes | Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Fruit Proteins [EXT] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 36987-1466-2
10 mL in 1 VIAL, MULTI-DOSE (36987-1466-2)
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 36987-1466-1 [36987146601]
Black Olive INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-1466-2 [36987146602]
Black Olive INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-1466-3 [36987146603]
Black Olive INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-1466-4 [36987146604]
Black Olive INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| BLACK OLIVE | .05 g/mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Food Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Allergens [CS]
- Dietary Proteins [CS]
- Fruit Proteins [EXT]
NDC Crossover Matching brand name "Black Olive" or generic name "Black Olive"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0268-6185 | BLACK OLIVE | Olive |
| 36987-1466 | Black Olive | Black Olive |
| 36987-1467 | Black Olive | Black Olive |
| 36987-1468 | Black Olive | Black Olive |
| 36987-1469 | Black Olive | Black Olive |
Trademark Results [Black Olive]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BLACK OLIVE 88393476 not registered Live/Pending |
Akzo Nobel Coatings International B.V. 2019-04-19 |
 BLACK OLIVE 85522076 not registered Dead/Abandoned |
OLIVINA NAPA VALLEY, LLC 2012-01-21 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.